日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Single Cell Analysis Reveals Dynamic Changes of Distinct Cell Populations in Human Nickel Allergy

单细胞分析揭示人类镍过敏中不同细胞群的动态变化

Schmidt, Marc; Knorz, Andrea; Meder, Katharina; Goller, Simon; Imdahl, Fabian; Rocca, Yamila; Goebeler, Matthias; Khoueiry, Pierre

Navigating second-line therapy after immunotherapy in advanced HCC☆

晚期肝细胞癌免疫治疗后二线治疗的策略☆

Vogel, Arndt; Saborowski, Anna; Rimassa, Lorenza; El-Khoueiry, Anthony

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

SWOG S1815:吉西他滨、顺铂和白蛋白紫杉醇与吉西他滨和顺铂治疗新诊断的晚期胆道癌的III期随机试验

Shroff, Rachna T; King, Gentry; Colby, Sarah; Scott, Aaron J; Borad, Mitesh J; Goff, Laura; Matin, Khalid; Mahipal, Amit; Kalyan, Aparna; Javle, Milind M; El Dika, Imane; Tan, Benjamin; Cheema, Puneet; Patel, Anuj; Iyer, Renuka; Kelley, R Katie; Thumar, Jaykumar; El-Khoueiry, Anthony; Guthrie, Katherine A; Chiorean, E Gabriela; Hochster, Howard; Philip, Philip A

Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic Sarcomas

Botensilimab(Fc增强型抗细胞毒性淋巴细胞相关蛋白-4抗体)联合Balstilimab(抗PD-1抗体)治疗复发/难治性转移性肉瘤患者

Wilky, Breelyn A; Schwartz, Gary K; Gordon, Michael S; El-Khoueiry, Anthony B; Bullock, Andrea J; Henick, Brian; Agulnik, Mark; Singh, Arun; Mahadevan, Daruka; Stebbing, Justin; Delepine, Chloe; Chand, Dhan; Avagyan, Manushak; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven; Trent, Jonathan C; Jones, Robin L; Tsimberidou, Apostolia M

Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial

阿特珠单抗联合化疗(加或不加贝伐珠单抗)治疗晚期胆道癌:来自随机II期IMbrave151试验的临床和生物标志物数据

Macarulla, Teresa; Ren, Zhenggang; Chon, Hong Jae; Park, Joon Oh; Kim, Jin Won; Pressiani, Tiziana; Li, Daneng; Zhukova, Lyudmila; Zhu, Andrew X; Chen, Ming-Huang; Hack, Stephen P; Wu, Stephanie; Liu, Bo; Guan, Xiangnan; Lu, Shan; Wang, Yulei; El-Khoueiry, Anthony B

Deep representation learning for clustering longitudinal survival data from electronic health records

基于深度表征的聚类方法,用于分析电子健康记录中的纵向生存数据

Qiu, Jiajun; Hu, Yao; Li, Li; Erzurumluoglu, Abdullah Mesut; Braenne, Ingrid; Whitehurst, Charles; Schmitz, Jochen; Arora, Jatin; Bartholdy, Boris Alexander; Gandhi, Shrey; Khoueiry, Pierre; Mueller, Stefanie; Noyvert, Boris; Ding, Zhihao; Jensen, Jan Nygaard; de Jong, Johann

Comprehensive molecular portrait reveals genetic diversity and distinct molecular subtypes of small intestinal neuroendocrine tumors

综合分子图谱揭示小肠神经内分泌肿瘤的遗传多样性和不同分子亚型

Céline Patte #, Roxane M Pommier #, Anthony Ferrari #, Felicia Fei-Lei Chung #, Maria Ouzounova, Pauline Moullé, Mathieu Richaud, Rita Khoueiry, Maëva Hervieu, Silvia Breusa, Marion Allio, Nicolas Rama, Laura Gérard, Valérie Hervieu, Gilles Poncet, Tanguy Fenouil, Vincent Cahais, Anne-Sophie Sertier

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors

TIMEPOINT 是一项将 MTL-CEBPA 与帕博利珠单抗联合使用的 1 期研究,该研究支持 MTL-CEBPA 在实体瘤中的免疫调节作用。

Ruth Plummer ,Mikael H Sodergren ,Rose Hodgson ,Bríd M Ryan ,Nina Raulf ,Joanna P Nicholls ,Vikash Reebye ,Jon Voutila ,Laura Sinigaglia ,Tim Meyer ,David J Pinato ,Debashis Sarker ,Bristi Basu ,Sarah Blagden ,Natalie Cook ,Thomas R Jeffrey Evans ,Jeffrey Yachnin ,Cheng E Chee ,Daneng Li ,Anthony El-Khoueiry ,Maria Diab ,Kai-Wen Huang ,Madhava Pai ,Duncan Spalding ,Thomas Talbot ,Marcus S Noel ,Bridget Keenan ,Devalingam Mahalingam ,Min-Sun Song ,Mélanie Grosso ,Denis Arnaud ,Aurelie Auguste ,Dimitris Zacharoulis ,Jan Storkholm ,Iain McNeish ,Robert Habib ,John J Rossi ,Nagy A Habib

Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study

肿瘤内注射INT230-6治疗晚期实体瘤成年患者的安全性和有效性:一项开放标签1/2期剂量递增研究的结果

Thomas, Jacob S; Siu, Lillian L; Ingham, Matthew; Azad, Nilofer S; Meyer, Christian F; Olszanski, Anthony J; Whalen, Giles F; Camacho, Luis H; Hu, James S; Hanna, Diana L; Cheng, Phillip M; Abdul Razak, Albiruni R; Abbate, Franco; Mahmood, Syed; Walters, Ian B; Bender, Lewis H; El-Khoueiry, Anthony B

Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer

在难治性卵巢癌患者中,Botensilimab(Fc增强型抗CTLA-4抗体)联合balstilimab(抗PD-1抗体)治疗方案

Porter, Rebecca; Bockorny, Bruno; Corr, Bradley R; Mahadevan, Daruka; Wilky, Breelyn A; El-Khoueiry, Anthony B; Bullock, Andrea J; Hafez, Navid; Moser, Justin; Martynova, Anastasia; Stebbing, Justin; Joshi, Bishnu; Bourdelais, Sean; Delepine, Chloe; Chand, Dhan; Wu, Wei; Johnson, Benny; Grossman, Joseph E; O'Day, Steven J; Matulonis, Ursula A; Gordon, Michael S